When these harmful substances accumulate in the body, they can lead to inflammation and cellular damage, ultimately impairing liver function
The last time I wrote on Novo Nordisk (NVO), it was with a Seeking Alpha article entitled " Novo Nordisk: CagriSema Sets Potential Obesity Drug Development Comeback ." With respect to this article, I Novo Nordisk: Downgrading To 'Sell' As GLP-1 Pipeline Faces Many Risks Summary Novo Nordisk is downgraded from 'Buy' to 'Sell' due to clinical setbacks, intensifying GLP-1 competition, and patent cliffs
Key takeaways There are no FDA-approved generic versions of many GLP-1 drugs, including Ozempic, Wegovy, Mounjaro, or Zepbound
They're tools, powerful tools, but they amplify good practices rather than compensating for bad ones
Heres what Semaglutide does in your body: Reduces appetite naturally You feel satisfied with smaller portions without constant hunger pangs or obsessive thoughts about food
